<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02940600</url>
  </required_header>
  <id_info>
    <org_study_id>687</org_study_id>
    <nct_id>NCT02940600</nct_id>
  </id_info>
  <brief_title>Efficacy Evaluation of Normothermic Perfusion Machine Preservation in Liver Transplant Using Very Old Donors</brief_title>
  <acronym>CEFEMA</acronym>
  <official_title>Pilot, Open, Monocentric, Randomized, Prospective Trial for the Evaluation of the Efficacy of Normothermic Perfusion Machine for Organ Preservation in Liver Transplantation Using Brain Death Donors Older or Equal Than 70 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero, Universitaria Pisana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero, Universitaria Pisana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of normothermic machine perfusion in
      liver transplantation using grafts of brain death donors older or equal than 70 years
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mean donor age for liver transplantation in Tuscany, Italy, is increasing and is actually 71
      years. Old donors are a valuable resource but their use has been related to a major incidence
      of primary non function (PNF), delayed graft function (DGF) and ischemic type biliary lesions
      (ITBL).

      Ischemia-reperfusion injury is a major reason for the development of these complications and
      and old grafts are more susceptible than younger ones.

      Normothermic machine perfusion (NMP) is a novel and promising technique that allows
      preservation in a more physiological environment. It is our belief that the use of NMP might
      reduce the impact of ischemia-reperfusion injuries in older grafts thus reducing the
      incidence of complications and providing a better outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 months graft survival</measure>
    <time_frame>180 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ischemia-reperfusion injury assessment through biopsies evaluation</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ischemia reperfusion injury assessment through transaminases</measure>
    <time_frame>7 days</time_frame>
    <description>AST level at post operative day number 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemia reperfusion injury assessment through incidence of ischemic type biliary lesions</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ischemic Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Normothermic machine perfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing liver transplant with grafts preserved using normothermic machine perfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Static cold storage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing liver transplant with statically cold preserved grafts</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Normothermic machine perfusion</intervention_name>
    <description>Patients undergoing liver transplant with the use of grafts preserved with normothermic perfusion machine</description>
    <arm_group_label>Normothermic machine perfusion</arm_group_label>
    <other_name>Liver Assist</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Static cold storage</intervention_name>
    <description>Patients undergoing liver transplant using statically cold preserved grafts</description>
    <arm_group_label>Static cold storage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient on waiting list for liver transplant

          -  Signed informed consent

          -  Age between 18 and 70

          -  Eligibility for liver transplant as for University of Pisa Liver Transplant Center
             Protocol

          -  Capacity and willingness to participate to the protocol

        Exclusion Criteria:

          -  No signed informed consent

          -  Age under 18 or over 70

          -  Presence of disease that may influence results

          -  Patient participation to other studies

          -  Re-liver transplant

          -  ABO incompatible OLT

          -  Multiorgan transplant

          -  Liver transplant for acute liver failure or trauma

          -  MELD (model for end stage liver disease) &gt;24

          -  Patient not suitable to participate on investigators's opinion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davide Ghinolfi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero, Universitaria Pisana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Davide Ghinolfi, MD, PhD</last_name>
    <phone>+39050995421</phone>
    <email>d.ghinolfi@ao-pisa.toscana.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniele Pezzati, MD</last_name>
    <phone>+393202172957</phone>
    <email>danypez@hotmail.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UO Chirurgia Epatica e del Trapianto di Fegato</name>
      <address>
        <city>Pisa</city>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Ghinolfi, MD</last_name>
      <phone>+39050995421</phone>
      <email>d.ghinolfi@ao-pisa.toscana.it</email>
    </contact>
    <contact_backup>
      <last_name>Daniele Pezzati, MD</last_name>
      <phone>+393202172957</phone>
      <email>danypez@hotmail.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Bral M, Gala-Lopez B, Bigam D, Kneteman N, Malcolm A, Livingstone S, Andres A, Emamaullee J, Russell L, Coussios C, West LJ, Friend PJ, Shapiro AM. Preliminary Single-Center Canadian Experience of Human Normothermic Ex Vivo Liver Perfusion: Results of a Clinical Trial. Am J Transplant. 2017 Apr;17(4):1071-1080. doi: 10.1111/ajt.14049. Epub 2016 Dec 9.</citation>
    <PMID>27639262</PMID>
  </reference>
  <reference>
    <citation>Mergental H, Perera MT, Laing RW, Muiesan P, Isaac JR, Smith A, Stephenson BT, Cilliers H, Neil DA, HÃ¼bscher SG, Afford SC, Mirza DF. Transplantation of Declined Liver Allografts Following Normothermic Ex-Situ Evaluation. Am J Transplant. 2016 Nov;16(11):3235-3245. doi: 10.1111/ajt.13875. Epub 2016 Jul 13.</citation>
    <PMID>27192971</PMID>
  </reference>
  <reference>
    <citation>Op den Dries S, Karimian N, Westerkamp AC, Sutton ME, Kuipers M, Wiersema-Buist J, Ottens PJ, Kuipers J, Giepmans BN, Leuvenink HG, Lisman T, Porte RJ. Normothermic machine perfusion reduces bile duct injury and improves biliary epithelial function in rat donor livers. Liver Transpl. 2016 Jul;22(7):994-1005. doi: 10.1002/lt.24436.</citation>
    <PMID>26946466</PMID>
  </reference>
  <reference>
    <citation>Ravikumar R, Jassem W, Mergental H, Heaton N, Mirza D, Perera MT, Quaglia A, Holroyd D, Vogel T, Coussios CC, Friend PJ. Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial. Am J Transplant. 2016 Jun;16(6):1779-87. doi: 10.1111/ajt.13708. Epub 2016 Mar 7.</citation>
    <PMID>26752191</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2016</study_first_submitted>
  <study_first_submitted_qc>October 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero, Universitaria Pisana</investigator_affiliation>
    <investigator_full_name>Davide Ghinolfi</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>normothermic perfusion</keyword>
  <keyword>old donors</keyword>
  <keyword>extended criteria grafts</keyword>
  <keyword>reconditioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

